Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues. It is caused by inhalation of contaminated dust or by infection of a wound.
Biomarker and diagnostic research for sporotrichosis has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy, other interventions, and medical devices. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
223 publications have been identified in PubMed for sporotrichosis. Kisho has analyzed 79 by research type. Research spans Review / Meta-Analysis (38%), Case Report / Case Series (23%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 30 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 9:40 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
38%
Patient case studies | 18 | 23% |
Disease patterns and progression | 13 | 16% |
Laboratory research | 8 | 10% |
Clinical study results | 5 | 6% |
Other research | 2 | 3% |
Testing and diagnosis research | 2 | 3% |
New treatment approaches | 1 | 1% |
Yurayart C (2026). [PMID: 42230305](https://pubmed.ncbi.nlm.nih.gov/42230305/). *Emerg Infect Dis*. [Basic Science / Preclinical]
Sur M (2026). [PMID: 30969613](https://pubmed.ncbi.nlm.nih.gov/30969613/). *Unknown Journal*. [Epidemiology / Natural History]
Chandler DJ (2026). [PMID: 41362932](https://pubmed.ncbi.nlm.nih.gov/41362932/). *Clin Exp Dermatol*. [Review / Meta-Analysis]
Reinprayoon U (2026). [PMID: 41733757](https://pubmed.ncbi.nlm.nih.gov/41733757/). *J Ophthalmic Inflamm Infect*. [Review / Meta-Analysis]
Rossi P (2026). [PMID: 41869106](https://pubmed.ncbi.nlm.nih.gov/41869106/). *Cureus*. [Case Report / Case Series]
Yuan D (2026). [PMID: 42088023](https://pubmed.ncbi.nlm.nih.gov/42088023/). *Front Cell Infect Microbiol*. [Review / Meta-Analysis]
Corrêa-Moreira D (2026). [PMID: 42071992](https://pubmed.ncbi.nlm.nih.gov/42071992/). *Animals (Basel)*. [Review / Meta-Analysis]
Smith DJ (2025). [PMID: 40225334](https://pubmed.ncbi.nlm.nih.gov/40225334/). *Lancet Reg Health Southeast Asia*. [Review / Meta-Analysis]
Dumont-Viollaz A (2025). [PMID: 40705328](https://pubmed.ncbi.nlm.nih.gov/40705328/). *Med Mycol*. [Review / Meta-Analysis]
Silva DL (2025). [PMID: 40172196](https://pubmed.ncbi.nlm.nih.gov/40172196/). *mBio*. [Review / Meta-Analysis]